首页> 美国卫生研究院文献>Clinical and Diagnostic Laboratory Immunology >Macaque Multimeric Soluble CD40 Ligand and GITR Ligand Constructs Are Immunostimulatory Molecules In Vitro
【2h】

Macaque Multimeric Soluble CD40 Ligand and GITR Ligand Constructs Are Immunostimulatory Molecules In Vitro

机译:猕猴多聚体可溶性CD40配体和GITR配体构建体是体外免疫刺激分子。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

CD40 ligand (CD40L) and GITR ligand (glucocorticoid-induced tumor necrosis factor receptor-related protein ligand [GITRL]) are tumor necrosis factor superfamily molecules that can be used as vaccine adjuvants. In a previous human immunodeficiency virus (HIV) DNA vaccine study in mice, we found that plasmids expressing multimeric soluble forms of trimeric CD40L (i.e., many trimers) were stronger activators of CD8+ T-cell responses than were single-trimer soluble forms or the natural membrane-bound molecule. This report describes similar multimeric soluble molecules that were constructed for studies in macaques. Both two-trimer and four-trimer forms of macaque CD40L were active in B-cell proliferation assays using macaque and human cells. With human cells, four-trimer macaque GITRL costimulated CD4+ T-cell proliferation and abrogated the immunosuppressive effects of CD4+ CD25+ regulatory T cells on a mixed leukocyte reaction. These molecular adjuvants provide new tools for vaccine development in the simian immunodeficiency virus system and other macaque models.
机译:CD40配体(CD40L)和GITR配体(糖皮质激素诱导的肿瘤坏死因子受体相关蛋白配体[GITRL])是肿瘤坏死因子超家族分子,可以用作疫苗佐剂。在先前的人类免疫缺陷病毒(HIV)DNA疫苗研究中,我们发现表达三聚体CD40L多聚体可溶形式的质粒(即许多三聚体)比CD8 + T细胞应答的激活剂更强。是单三聚体可溶形式或天然的膜结合分子。该报告描述了为猕猴研究而构建的类似的多聚体可溶性分子。猕猴CD40L的两个三聚体和四个三聚体形式在使用猕猴和人细胞的B细胞增殖测定中均具有活性。在人类细胞中,四聚体猕猴GITRL共同刺激CD4 + T细胞增殖,并废除了CD4 + CD25 + 调节性T细胞的免疫抑制作用混合白细胞反应。这些分子佐剂为猿猴免疫缺陷病毒系统和其他猕猴模型中的疫苗开发提供了新的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号